[1]
Megrelishvili, T. и др. 2022. EFFICACY OF PAXLOVIDE IN THE TREATMENT OF COVID-19 PATIENTS WITH DIABETES TYPE 2. Сборник научных трудов ТГМУ. 56, (ноя. 2022), 92–95. DOI:https://doi.org/10.52340/csw.2022.56.01.01.